Juergen Froehlich
Technik-/Wissenschafts-/F&E-Leiter bei ARCTURUS THERAPEUTICS HOLDINGS INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Juergen Froehlich
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
APPILI THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 27.01.2020 | - |
Independent Dir/Board Member | 27.01.2020 | - | |
SPEXIS AG | Technik-/Wissenschafts-/F&E-Leiter | 30.12.2021 | - |
ARCTURUS THERAPEUTICS HOLDINGS INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Vertrieb & Marketing | 01.03.2023 | - |
Karriereverlauf von Juergen Froehlich
Ehemalige bekannte Positionen von Juergen Froehlich
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
EnBiotix, Inc.
EnBiotix, Inc. Medical/Nursing ServicesHealth Services EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA. | Vertrieb & Marketing | 01.01.2022 | 01.04.2023 |
ARADIGM CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 31.05.2018 | 14.02.2019 |
ARADIGM CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2013 | 11.02.2018 |
General Counsel | 01.11.2013 | 11.02.2018 | |
VERTEX PHARMACEUTICALS INCORPORATED | General Counsel | 01.10.2011 | 01.09.2013 |
Ausbildung von Juergen Froehlich
Julius-Maximilians-Universität Würzburg | Doctorate Degree |
State University of New York at Albany | Masters Business Admin |
Graduate School of Business Administration Zürich | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 6 |
Schweiz | 3 |
Deutschland | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 4 |
General Counsel | 2 |
Masters Business Admin | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 4 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
APPILI THERAPEUTICS INC. | Health Technology |
SPEXIS AG | Health Technology |
ARCTURUS THERAPEUTICS HOLDINGS INC. | Health Technology |
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
Private Unternehmen | 2 |
---|---|
Aradigm Corp.
Aradigm Corp. Pharmaceuticals: MajorHealth Technology Aradigm Corp. was a pharmaceutical company, which was focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. The company was founded in 1991 and was headquartered in Hayward, CA. | Health Technology |
EnBiotix, Inc.
EnBiotix, Inc. Medical/Nursing ServicesHealth Services EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA. | Health Services |
- Börse
- Insiders
- Juergen Froehlich
- Erfahrung